Predictors of high defibrillation threshold in the modern era

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 2, 2013, Pages 231-237

  Lin, Edward F ^a   Dalal, Darshan ^a   Cheng, Alan ^a   Marine, Joseph E ^a   Nazarian, Saman ^a   Sinha, Sunil ^a   Spragg, David D ^a   Tandri, Harikrishna ^a   Halperin, Henry ^a   Calkins, Hugh ^a   Berger, Ronald D ^a   Tomaselli, Gordon F ^a   Henrikson, Charles A ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

high defibrillation threshold; implantable cardioverter defibrillator; threshold testing

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATION THRESHOLD; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; WAVEFORM;

AGE DISTRIBUTION; CARDIOMYOPATHIES; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; DIFFERENTIAL THRESHOLD; EQUIPMENT SAFETY; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MARYLAND; MIDDLE AGED; RISK ASSESSMENT; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION;

EID: 84873380816     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12039     Document Type: Article

References (23)

1. Gold M, Khalighi K, Kavesh N, Daly B, Peters R, Shorofsky S,. Clinical predictors of transvenous biphasic defibrillation thresholds. Am J Cardiol 1997; 79: 1623-1627.
2. Epstein A, Ellenbogen K, Kirk K, Kay G, Dailey S, Plumb V,. Clinical characteristics and outcome of patients with high defibrillation thresholds. Circulation 1992; 86: 1206-1216.
3. Huang S, Tan de Guzman W, Chenarides J, Okike N, Vander Salm T,. Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator. Am Heart J 1991; 122: 720-727.
4. Kelly P, Cannom D, Garan H, Mirabal G, Harthorne J, Hurvitz R, Vlahakes G, et al. The automatic implantable cardioverter-defibrillator: Efficacy, complications, and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 1988; 11: 1278-1286.
5. Winkle R, Mead R, Ruder M, Gaudiani V, Smith N, Buch W, Schmidt P, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 13: 1353-1361.
6. Manolis A, Tan-DeGuzman W, Lee M, Rastegar H, Haffajee C, Huang S, Estes N III,. Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator. Am Heart J 1989; 118: 445-450.
7. Runsiö M, Bergfeldt L, Brodin L, Ribeiro A, Samuelsson S, Rosenqvist M,. Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transesophageal echocardiography. Eur Heart J 1997; 18: 124-131.
8. Tokano T, Bach D, Chang J, Davis J, Souza J, Zivin A, Knight B, et al. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol 1998; 9: 791-797.
9. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes F, Krahn A, et al. Complications associated with defibrillation threshold testing: The Canadian experience. Heart Rhythm 2008; 5: 387-390.
10. Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, et al. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008; 52: 551-556.
11. Raitt M, Johnson G, Dolack G, Poole J, Kudenchuk P, Bardy G,. Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system. J Am Coll Cardiol 1995; 25: 1576-1583.
12. Shukla H, Flaker G, Jayam V, Roberts D,. High defibrillation thresholds in transvenous biphasic implantable defibrillators: Clinical predictors and prognostic implications. Pacing Clin Electrophysiol 2003; 26: 44-48.
13. Pinski S, Vanerio G, Castle L, Morant V, Simmons T, Trohman R, Wilcoff B, et al. Patients with a high defibrillation threshold: Clinical characteristics, management, and outcome. Am Heart J 1991; 122: 89-95.
14. Healey JS, Birnie DH, Lee DS, Krahn AD, Crystal E, Simpson CS, Dorian P, et al. Defibrillation testing at the time of ICD insertion: An analysis from the Ontario ICD Registry. J Cardiovasc Electrophysiol 2010; 21: 1344-1348.
15. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, et al. Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2005; 2: 456-461.
16. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
17. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
18. Neuzner J, Bahawar H, Berkowitsch A, Michel U, Schlepper M, Pitschner H,. Clinical predictors of defibrillation energy requirements. Am J Cardiol 1997; 79: 205-206.
19. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 1996; 94: 690-697.
20. Jankowska EA, Ponikowski P, Piepoli MF, Banasiak W, Anker SD, Poole-Wilson PA,. Autonomic imbalance and immune activation in chronic heart failure-Pathophysiological links. Cardiovasc Res 2006; 70: 434-445.
21. Floras JS,. Sympathetic activation in human heart failure: Diverse mechanisms, therapeutic opportunities. Acta Physiol Scand 2003; 177: 391-398.
22. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990; 82: 1724-1729.
23. Morillo CA, Jones DL, Klein GJ,. Effects of autonomic manipulation on ventricular fibrillation and internal cardiac defibrillation thresholds in pigs. Pacing Clin Electrophysiol 1996; 19: 1355-1362.